Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 26, 2017, to report its financial results for the third quarter ended September 30, 2017. The key information is contained within the press release furnished as Exhibit 99.1, which details the company's performance during the period. Investors should refer to this press release for specific financial metrics, operational achievements, and management commentary on the results. This filing serves as the official notification of BSX's quarterly performance and provides the basis for understanding the company's current financial standing and future outlook. While the 8-K itself is brief, the accompanying press release is crucial for a comprehensive understanding of the third quarter's financial condition and results of operations. The information presented is not considered 'filed' for certain regulatory purposes but is made available to the public for informational transparency.
Key Highlights
- 1Boston Scientific announced its third-quarter 2017 financial results on October 26, 2017.
- 2The company issued a press release detailing its performance for the quarter ended September 30, 2017.
- 3The 8-K filing includes Exhibit 99.1, which is the press release containing the financial results.
- 4Investors are directed to the furnished press release for detailed financial information.
- 5This filing does not include the financial statements directly but refers to an external document.
- 6The information furnished is for informational purposes and not deemed 'filed' under Section 18 of the Exchange Act.